Investment Summary |
|
|---|---|
| Date | 2015-04-07 |
| Target | Nabriva Therapeutics |
| Sector | Life Science |
| Investor(s) | Vivo Capital |
| Deal Type | Venture |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 6.4B USD |
| Size | Mega |
| Type | Sector Focused |
Vivo Capital is a healthcare investment firm focused on opportunities throughout the US and China. Specific areas of interest include biopharmaceuticals, specialty pharmaceuticals, and medical devices. The Firm looks to identify and work with companies at the development and commercial stage products in the US and at the revenue stage in China. Vivo Capital was established in 1997 and is headquartered in Palo Alto, California.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 18 |
| Sector: Life Science M&A | 4 of 13 |
| Type: Venture M&A Deals | 5 of 13 |
| Country: Ireland M&A | 1 of 1 |
| Year: 2015 M&A | 3 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-03-05 |
Tricida
South San Francisco, California, United States Tricida is a pharmaceutical company focused on developing and commercializing its drug candidate, TRC101, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD). Tricida was founded in 2013 and is based in South San Francisco, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-05-26 |
AirXpanders
San Francisco, California, United States AirXpanders is a medical device company focused on the design, manufacture, sale, and distribution of its AeroForm tissue expander, which is approved for sale in Europe and Australia. AirXpanders is based in San Francisco, California. |
Buy | - |
